Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.01 -0.01 (-0.98%)
At close: Oct 22, 2026 · 4:00 PM EDT

Telomir Pharmaceuticals (TELO) Price to Sales (2025)

Updated

Analysis

Telomir Pharmaceuticals (TELO) Price to Sales (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Telomir Pharmaceuticals 69.46 Mn 48.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 695.61
Jun 30, 2025 779.79
API Access

Telomir Pharmaceuticals Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=TELO&period=max&api_key=YOUR_API_KEY